Skip to content

Long-term Follow-up of Living Liver Donors: A Single-center Experience

Long-term Follow-up of Living Liver Donors: A Single-center Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04814290
Enrollment
476
Registered
2021-03-24
Start date
2004-05-01
Completion date
2021-01-01
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Keywords

Living-donor liver transplantation, Quality of life, Follow up

Brief summary

Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.

Detailed description

Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up. We used the 36-item short-form health survey (short form-36 health survey, version 1 \[SF-36\]). The scores for the 4 following subscales were higher in nondonors than in donors: physical functioning (P = 0.009), role limitations due to physical health (P = 0.002), energy/fatigue (P \< 0.001), and bodily pain (P \< 0.001). The scores on the 8 subscales of the SF-36 were higher in donors with living recipients than in donors whose recipients died (P \< 0.001). Our results suggest that living donor right hepatectomy is safe and results in a postdonation HRQoL similar to that of nondonors in those donors whose recipients are healthy, while donors whose recipients die have a lower HRQoL that is significantly negatively correlated with the time since recipient death and improves over time.

Interventions

OTHERhealth-related quality of life (HRQoL) (36-item short-form health survey, version 1 [SF-36]).

health-related quality of life (HRQoL) (36-item short-form health survey, version 1 \[SF-36\]).

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years

Inclusion criteria

* age 18-50 years * no comorbidities. * BMI less than 30 kg/m2. * compatible ABO group.

Exclusion criteria

* Older than 50 years. * Associated comorbidities. * Obesity. * Noncompatible ABO group.

Design outcomes

Primary

MeasureTime frameDescription
health-related quality of life (HRQoL)4 to 16 years of follow uphealth-related quality of life (HRQoL) (36-item short-form health survey, version 1 \[SF-36\]).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026